Walden University -NURS-6630: Approaches to Treatments. WeeK4 Assignment.

Document Content and Description Below

Walden University -NURS-6630: Approaches to Treatments. WeeK4 Assignment. Bipolar Disorder: Asian American Woman Bipolar I disorder is a major psychiatric illness categorized by alternating episo... des of either extreme depressive or manic moods (Gooding, Wolford, & Gooding, 2018). Although some individuals may experience both depressive and manic moods, at least one manic or mixed episode must occur in order to be diagnosed (Stahl, 2013). The National Comorbidity Survey Replication has estimated that the prevalence of Bipolar disorder in the past year has affected approximately 2.8% of U. S. adults (Bipolar Disorder, 2017). According to Cheang (2018), Asian Americans are three times less probable to pursue mental health services than other ethnic backgrounds. References American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). Arlington, VA: American Psychiatric Publishing. Bipolar Disorder. (2017). National Institute of Mental Health. Retrieved from https://www.nimh.nih.gov/health/statistics/bipolar-disorder.shtml Cheang, J. (2018). Asian American Mental Health and the ‘Model Minority Myth’. Asian Community Mental Health Services. Retrieved from https://www.acmhs.org/2018/05/asian-american-mental-health-and-the-model-minority-myth/ Cochoran, S. D. (1984) Preventing medical non-compliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology, 52, 879-884. DeJongh, B. (2012) Lithium use in bipolar disorder: Summary of evidence for acute mania, acute depression, and maintenance treatment. Mental Health Clinician, 2 (1)1, 10-14. https://doi.org/10.9740/mhc.n110748 Dodgen, T. M., Eloff, A., Mataboge, C., Roos, L., Van Staden, W., & Pepper, M. S. (2015). Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort. Applied & Translational Genomics, 5, 40-46. doi:10.1016/j.atg.2015.05.001 Girardi, P., Brugnoli, R., Manfredi, G., & Sani, G. (2016). Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations. Drugs in R&D, 16(4), 293-302. Gooding, D. C., Wolford, K., & Gooding, D. C. (2018). Bipolar disorder. Salem Press Encyclopedia of Health. Retrieved from https://ezp.waldenulibrary.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ers&AN=93871807&site=eds-live&scope=site Emami, J., Tavakoli, N., & Movahedian, A. (2004). Formulation of sustained-release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation. J Pharm Pharmaceutical Science, 7(3) 338-344. Retrieved from https://sites.ualberta.ca/~csps/JPPS7(3)/J.Emami/lc.htm Harvey, N. S., & Peet, M. (1991). Lithium Maintenance: 2. Effects of Personality and Attitude on Health Information Acquisition and Compliance. British Journal of Psychiatry, 158, 200-204. Retrieved from https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F14CA32431E35A3928C2BBEF14B034B8/S0007125000107251a.pdf/lithium_maintenance_2_effects_of_personality_and_attitude_on_health_information_acquisition_and_compliance.pdf Laureate Education. (2016f). Case study: An Asian American woman with bipolar disorder [Interactive media file]. Baltimore, MD: Author Lithobid. (2009). Noven Therapeutics, LLC. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018027s056lbl.pdf Machado-Vieira, R., Manji, H. K., & Zarate, C. A. (2009). The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar disorders, 11, 92-109. Peselow, E.D., Long, R., Steiner, A. J., Pizano, D. R., Naghdechi, L., Akladios, N., & IsHak, W. W. (2016). Factors Affecting Long-term Lithium Compliance in Bipolar Patients. International Neuropsychiatric Disease Journal, 7(4): 1-8. Puangpetch, A., Vanwong, N., Nuntamool, N., Hongkaew, Y., Chamnanphon, M., & Sukasem, C. (2016). CYP2D6 Polymorphisms and their influence on risperidone treatment. Dovepress, 2016(9), 131-147. https://doi.org/10.2147/PGPM.S107772 Schou, M. (1997). The combat of non-compliance during prophylactic lithium treatment. National Center for Biotechnology Information, 95(5) 361-363. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9197898 Smith, D. (2003). Five Principles for Research Ethics. American Psychological Association, 34(1), 56. Retrieved from https://www.apa.org/monitor/jan03/principles.aspx Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications. (4th ed.). New York, NY: Cambridge University Press. Stahl, S. M. (2017). The prescriber’s guide (6th ed.). New York, NY: Cambridge University Press. Suzuki, Y., Fukui, N., Tsuneyama, N., Watanabe, J., Ono, S., Sugai, T., & Someya, T. (2012). Effect of the cytochrome P450 2D610 allele on risperidone metabolism in Japanese psychiatric patients. Human Psychopharmacology: Clinical and Experimental, 27(1), 43–46. https://doi-org.ezp.waldenulibrary.org/10.1002/hup.1260 Yagihashi, T., Mizuno, M., Chino, B., Sato, Y., Sakuma, K., Takebayashi, T., & Kosaki, K. (2009). Effects of the CYP2D610 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia. Human Psychopharmacology: Clinical and Experimental, 24(4), 301–308. https://doi-org.ezp.waldenulibrary.org/10.1002/hup.1025 [Show More]

Last updated: 1 year ago

Preview 1 out of 10 pages